Michael Ronzetti
Impact in
-
- Cancer, Lipids, and Metabolism
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- Ferroptosis and cancer prognosis
Papers in
-
- bioluminescence and chemiluminescence research 2
- Protein purification and stability 2
-
- Cell Image Analysis Techniques 3
- Co-authors
- Elias S.J. Arnér (1 shared paper)Qing Cheng (1 shared paper)Dorian M. Cheff (1 shared paper)Karoline Scholzen (1 shared paper)Chuying Huang (1 shared paper)Radosveta Gencheva (1 shared paper)Matthew D. Hall (1 shared paper)Anton Simeonov (8 shared papers)
- Journals
- Expert Opinion on Drug Discovery (3 papers)mBio (2 papers)Scientific Reports (1 paper)Infection and Immunity (1 paper)Frontiers in Pharmacology (1 paper)
- Partner nations
- United StatesHungarySweden
In The Last Decade
Michael Ronzetti
12 papers receiving 196 citations
Michael Ronzetti's Hit Papers
Peers
Comparison fields: 5 of 52
- Cancer Research 65
- Pulmonary and Respiratory Medicine 87
- Molecular Biology 134
- Oncology 27
- Nutrition and Dietetics 14
Countries citing papers authored by Michael Ronzetti
This map shows the geographic impact of Michael Ronzetti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Ronzetti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Ronzetti more than expected).
Fields of papers citing papers by Michael Ronzetti
This network shows the impact of papers produced by Michael Ronzetti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Ronzetti. The network helps show where Michael Ronzetti may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael Ronzetti, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | The ferroptosis inducing compounds RSL3 and ML162 are not direct inhibitors of GPX4 but of TXNRD1 Hit paper breakdown → | 2023 | 127 |
| 2 | 2018 | 18 | |
| 3 | 2022 | 13 | |
| 4 | 2022 | 12 | |
| 5 | 2022 | 7 | |
| 6 | 2022 | 6 | |
| 7 | 2022 | 5 | |
| 8 | 2025 | 4 | |
| 9 | 2022 | 3 | |
| 10 | 2023 | 2 | |
| 11 | 2025 | 1 | |
| 12 | 2019 | 1 |
About Michael Ronzetti
Michael Ronzetti is a scholar working on Molecular Biology, Biophysics, Parasitology, Infectious Diseases and Immunology, having authored 12 papers that have together received 199 indexed citations. Recurring topics across this work include Cell Image Analysis Techniques (3 papers), Vector-borne infectious diseases (3 papers), bioluminescence and chemiluminescence research (2 papers), Protein purification and stability (2 papers), Viral Infections and Vectors (2 papers), Nanoplatforms for cancer theranostics (1 paper), Computational Drug Discovery Methods (1 paper) and Bee Products Chemical Analysis (1 paper). The work is most often cited by research in Cancer Research (65 citations), Pulmonary and Respiratory Medicine (87 citations), Molecular Biology (134 citations), Oncology (27 citations) and Nutrition and Dietetics (14 citations). Michael Ronzetti has collaborated with scholars based in United States, Hungary and Sweden. Frequent co-authors include Elias S.J. Arnér, Qing Cheng, Dorian M. Cheff, Karoline Scholzen, Chuying Huang, Radosveta Gencheva, Matthew D. Hall, Anton Simeonov, Bolormaa Baljinnyam and Adam Yasgar. Their work appears in journals such as Expert Opinion on Drug Discovery, mBio, Scientific Reports, Infection and Immunity and Frontiers in Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.